Reproductive Medical Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, China.
Wuhan Institute of Dermatology and Venerology, Wuhan, China.
Reprod Biol Endocrinol. 2020 Feb 29;18(1):16. doi: 10.1186/s12958-020-00571-6.
To investigate the effectiveness of the GnRH-a ultra-long protocol, GnRH-a long protocol, and GnRH-a short protocol used in in vitro fertilization-embryo transfer (IVF-ET) in infertile women with endometriosis.
We searched PubMed, Embase, Web of Science, Cochrane Library, Elsevier Science Direct, OA Library, Google Scholar, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, China Science and Technology Journal database, and the China Biology Medicine disc for randomized controlled trials (RCTs) and observational studies (non-RCTs) to evaluate the efficacy of the GnRH-a ultra-long protocol, GnRH-a long protocol, and GnRH-a short protocol in IVF-ET in infertile patients with endometriosis.
A total of 21 studies in compliance with the standard literature were included, and RCT and non-RCT studies were analyzed separately. This meta-analysis showed that the GnRH-a ultra-long protocol could improve the clinical pregnancy rate of infertile patients in RCT studies, especially in patients with stages III-IV endometriosis (RR = 2.04, 95% CI: 1.37~3.04, P < 0.05). However, subgroup analysis found the different down-regulation protocols provided no significant difference in improving clinical outcomes in patients with endometriosis in the non-RCT studies.
This study suggests that the GnRH-a ultra-long protocol can improve the clinical pregnancy rate of the patients with stages III-IV endometriosis in RCT studies. Although it is generally believed that the results of RCT are more reliable, the conclusions of the non-RCT studies cannot be easily neglect, which let us draw conclusions more cautious.
探讨促性腺激素释放激素激动剂(GnRH-a)超长、长、短方案在子宫内膜异位症不孕患者体外受精-胚胎移植(IVF-ET)中的有效性。
检索 PubMed、Embase、Web of Science、Cochrane 图书馆、Elsevier Science Direct、OA 图书馆、Google Scholar、中国知网(CNKI)、万方数据知识服务平台、中国科技期刊数据库和中国生物医学文献数据库,纳入 GnRH-a 超长、长、短方案治疗子宫内膜异位症不孕患者 IVF-ET 的随机对照试验(RCT)和观察性研究(非 RCT)。
共纳入 21 项符合标准的文献,分别对 RCT 和非 RCT 研究进行分析。该荟萃分析显示,GnRH-a 超长方案可提高 RCT 研究中不孕患者的临床妊娠率,尤其是在 III-IV 期子宫内膜异位症患者中(RR=2.04,95%CI:1.37~3.04,P<0.05)。然而,亚组分析发现,非 RCT 研究中不同的下调方案对改善子宫内膜异位症患者的临床结局无显著差异。
本研究提示 GnRH-a 超长方案可提高 RCT 研究中 III-IV 期子宫内膜异位症患者的临床妊娠率。虽然普遍认为 RCT 结果更可靠,但不能轻易忽视非 RCT 研究的结论,这让我们更谨慎地得出结论。